Catalent

Catalent facing board shake-up pressure from activist investor Elliott
Fierce Pharma
Fri, 07/21/23 - 10:06 am
Catalent
investors
activist investors
CDMO
Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance
BioSpace
Tue, 05/9/23 - 10:37 am
Catalent
earnings
CDMOs
Danaher backs away from Catalent as CDMO struggles with productivity problems: report
Fierce Pharma
Tue, 04/18/23 - 10:15 am
Catalent
Danaher
M&A
CDMOs
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
Investors Business Daily
Tue, 02/7/23 - 11:14 am
Catalent
Danaher
Thermo Fisher Scientific
M&A
Sarepta marches forward with its potential DMD gene therapy and an expanded Catalent manufacturing deal
Endpoints
Thu, 01/5/23 - 04:58 pm
Sarepta Therapeutics
SRP-9001
gene therapy
Duchenne Muscular Dystrophy
CDMOs
Catalent
Catalent to build a new $40M analytical services facility in North Carolina's Research Triangle
Endpoints
Wed, 12/14/22 - 07:25 pm
Catalent
North Carolina
RTP
analytical services
R&D
Exelixis Inks Third Collaboration Deal in a Week, This Time with Catalent
BioSpace
Thu, 11/3/22 - 07:34 pm
Exelixis
Catalent
antibody-drug conjugate
Catalent buys partially built biologics plant with plans to shell out $160M to finish it
Fierce Pharma
Thu, 04/7/22 - 10:32 am
CDMOs
Catalent
biologics
drug manufacturing
Catalent completes $30m expansion to biologics network
Biopharma Reporter
Tue, 03/22/22 - 10:03 am
Catalent
drug manufacturing
biologics
Novo Nordisk's Wegovy, hamstrung by Catalent FDA write-up, could correct course by mid-2022: analysts
Fierce Pharma
Thu, 01/27/22 - 10:47 am
Novo Nordisk
Catalent
Wegovy
obesity
FDA
Inside the Catalent FDA citation said to trigger Novo Nordisk's Wegovy supply hiccup
Fierce Pharma
Tue, 01/18/22 - 10:49 am
Catalent
FDA
Novo Nordisk
Wegovy
supply chain
In $1B buyout, Catalent takes on gummy company to jump into a booming market
Endpoints
Mon, 08/30/21 - 11:01 am
Catalent
CDMOs
Bettera
M&A
AstraZeneca in talks to produce COVID-19 vaccine for feds at Catalent site in Maryland: report
Fierce Pharma
Thu, 06/3/21 - 10:55 am
AstraZeneca
COVID-19
vaccines
Catalent
drug manufacturing
Contract drug maker Catalent to double production of Moderna COVID vaccine: WSJ
Marketwatch
Tue, 04/6/21 - 10:18 am
Catalent
CDMOs
Moderna Therapeutics
vaccines
COVID-19
drug manufacturing
Catalent signs on to produce Aurinia's newly approved lupus nephritis drug
Fierce Pharma
Mon, 02/22/21 - 10:46 am
Catalent
Aurinia Pharmaceuticals
lupus nephritis
Lupkynis
CDMOs
Catalent continues big push into cell and gene therapies with Belgian facility buyout
Fierce Pharma
Fri, 10/30/20 - 10:39 am
CDMO
Catalent
Belgium
cell therapy
gene therapy
AstraZeneca ropes in Catalent gene therapy site to produce viral vectors for COVID-19 vaccine
Fierce Pharma
Mon, 08/24/20 - 10:15 am
AstraZeneca
Catalent
CDMO
vaccines
COVID-19
Moderna and Catalent announce collaboration for fill-finish manufacturing of Moderna’s Covid-19 vaccine candidate
Pharmaceutical Business Review
Mon, 06/29/20 - 10:10 am
Moderna Therapeutics
Catalent
drug manufacturing
vaccines
COVID-19
pandemic
mRNA-1273
Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal
Fierce Pharma
Thu, 06/25/20 - 10:56 am
Moderna Therapeutics
vaccines
pandemic
COVID-19
Catalent
CDMO
Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 Vaccine
Reuters
Mon, 05/4/20 - 10:45 am
Arcturus Therapeutics
Catalent
vaccines
COVID-19

Pages